Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes.

Garg, Satish K.; Potts, Russell O.; Ackerman, Neil R.; Fermi, Steven J.; Tamada, Janet A.; Chase, H. Peter

doi:10.2337/diacare.22.10.1708

Cited by 186 publications

(88 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…approximately 5-20 % of patients suffer from erythema, edema, or skin irritation due to the sensor adhesive. 10,12,13 another disadvantage of cGM is the time lag between the blood glucose value and the interstitial glucose value. The time lag is related to errors in SMBG and is especially accentuated with a higher rate of change of glucose greater than 2 mg/dl/minute (0.1 mmol/l/minute).…”

mentioning

confidence: 99%

Future Perspectives in Glucose Monitoring Sensors

Frontino¹,

Meschi²,

Bonfanti³

et al. 2013

US Endocrinology

View full text Add to dashboard Cite

The prevalence of diabetes is increasing. improved glucose control is fundamental to reduce both long-term micro-and macrovascular complications and short-term complications, such as diabetic ketoacidosis and severe hypoglycemia. Frequent blood glucose monitoring is an essential part of diabetes management. however, almost all available blood glucose monitoring devices are invasive. This determines a reduced patient compliance, which in turn reflects negatively on glucose control. Therefore, there is a need to develop noninvasive glucose monitoring devices that will reduce the need of invasive procedures, thus increasing patient compliance and consequently improving quality of life and health of patients with diabetes.

show abstract

mentioning

confidence: 99%

Future Perspectives in Glucose Monitoring Sensors

Frontino¹,

Meschi²,

Bonfanti³

et al. 2013

US Endocrinology

View full text Add to dashboard Cite

show abstract

“…We have evaluated the relationship between BG and glucose extracted from interstitial fluid using a GlucoWatch (Cygnus, Redwood City, CA) biographer. This is an Food and Drug Administrationapproved device used to detect trends and track patterns in glucose levels (3)(4)(5). It works through a process called reverse iontophoresis (6), which allows the biographer to collect glucose samples from subcutaneous interstitial space through intact skin by application of a low-level electric current.…”

mentioning

confidence: 99%

Physiological Differences Between Interstitial Glucose and Blood Glucose Measured in Human Subjects

et al. 2003

View full text Add to dashboard Cite

OBJECTIVE -This study investigated whether glucose readings from a sensor sampling in interstitial fluid differ substantially from blood glucose (BG) values measured at the same time.RESEARCH DESIGN AND METHODS -We have evaluated the relationship between BG and glucose extracted from interstitial fluid using the GlucoWatch (Cygnus, Redwood City, CA) biographer, a device that collects glucose from subcutaneous interstitial space through intact skin by application of a low electric current. We evaluated the relative change in the interstitial glucose (IG) signal (IGS) as measured by the biographer versus BG using a normalized two-point sensitivity index (NSI).RESULTS -The results show that biographer measures of IG differ in time and magnitude from the corresponding BG values. In particular, the biographer values were shifted in time due to instrumental and physiological lag. Results show an average total lag of 17.2 Ϯ 7.2 min for all subjects evaluated. The instrumental lag was 13.5 min, suggesting that physiological lag is ϳ5 min. In addition, when glucose was increasing, the change in IGS was less than that in BG, while when BG was decreasing, the change in IGS was greater than that in BG.CONCLUSIONS -Similar results have been reported for other measures of IG, suggesting that differences reflect physiological variation in glucose uptake, utilization, and elimination in blood and interstitial space. This further evidence of the difference between IG and BG should be considered when interpreting glucose measurements from devices that sample interstitial fluid.

show abstract

“…The GlucoWatch biographer (Cygnus, Redwood City, CA) provides frequent, automatic, and noninvasive glucose measurements-up to three readings per hour for as long as 12 h after a blood glucose measurement for calibration. Clinical studies in controlled and home environments have demonstrated high accuracy and precision (2,3). The results presented here evaluate the hypoglycemia alert performance in a large and demographically diverse patient population using the biographer both in controlled and normal daily environments.…”

mentioning

confidence: 99%

Detection of Hypoglycemia With the GlucoWatch Biographer

Pitzer

Desai²,

Dunn³

et al. 2001

Diabetes Care

118

View full text Add to dashboard Cite

OBJECTIVE -Hypoglycemia is a common acute complication of diabetes therapy. The GlucoWatch biographer provides frequent and automatic glucose measurements with an adjustable low-glucose alarm. We have analyzed the performance of the biographer low-glucose alarm relative to hypoglycemia as defined by blood glucose Յ3.9 mmol/l. RESEARCH DESIGN AND METHODS -The analysis was based on 1,091 biographer uses from four clinical trials, which generated 14,487 paired (biographer and blood glucose) readings.RESULTS -The results show that as the low-glucose alert level of the biographer is increased, the number of true positive alerts (alarm sounds and blood glucose Յ3.9 mmol/l) and false positive alerts (alarm sounds but blood glucose Ͼ3.9 mmol/l) increased. When analyzed as a function of varying low-glucose alert levels, the results show receiver operator characteristic curves consistent with a highly useful diagnostic tool. Setting the alert level from 1.1 to 1.7 mmol/l above the level of concern is likely to optimize the trade-off between true positives and false positives for each user. When the same blood glucose data are analyzed for typical monitoring practices (two or four measurements per day), the results show that fewer hypoglycemic events are detected than those detected with the biographer.CONCLUSIONS -The frequent and automatic nature of the biographer readings allows more effective detection of hypoglycemia than that achieved with current medical practice. Diabetes Care 24:881-885, 2001H ypoglycemia is a common acute complication of diabetes therapy. The frequency of severe hypoglycemia has been shown to increase with more intensive treatment. Increasing the frequency of glucose measurements, regardless of the technique used, makes it possible to detect a greater number of hypoglycemic events. However, as many as seven glucose measurements per day may fail to detect hypoglycemic events (1).A device providing automatic readings could make frequent monitoring easier and enable an alarm to be sounded in response to glucose readings below userselected alert levels. Such an alarm could reduce the risk of hypoglycemia, making intensive therapy safer and more acceptable for patients. The GlucoWatch biographer (Cygnus, Redwood City, CA) provides frequent, automatic, and noninvasive glucose measurements-up to three readings per hour for as long as 12 h after a blood glucose measurement for calibration. Clinical studies in controlled and home environments have demonstrated high accuracy and precision (2,3). The results presented here evaluate the hypoglycemia alert performance in a large and demographically diverse patient population using the biographer both in controlled and normal daily environments. The accuracy and precision results from these studies have been described (4).The performance of the hypoglycemia alert depends on the selection of a low-glucose alert level that will trigger an audible alarm. The performance of the alert function can be best evaluated by an analysis of the receiver operator characteri...

show abstract

Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes.

Abstract: This study confirms the accuracy and precision of glucose values as determined using the GlucoWatch biographer in clinic and home settings.

Cited by 186 publications

References 0 publications

Future Perspectives in Glucose Monitoring Sensors

Future Perspectives in Glucose Monitoring Sensors

Physiological Differences Between Interstitial Glucose and Blood Glucose Measured in Human Subjects

Detection of Hypoglycemia With the GlucoWatch Biographer

Contact Info

Product

Resources

About